Skip to main content
. 2000 Apr 24;2000(2):CD002139. doi: 10.1002/14651858.CD002139

a08 SGACLC 1.

Methods RCT ‐ 1982‐85
Participants 306 patients
Interventions surgery vs surgery + chemotherapy
 mitomycin C 0.08‡
 cyclophosphamide 2‡
 tegafur* 12‡
Outcomes survival
Notes mitomycin C given in 10 cycles
 tegafur daily treatment > 6 months
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment (selection bias) Low risk A ‐ Adequate